Express
Stock of Sorrento Therapeutics Increased by 178% After the Company Claimed Finding COVID-19 Antibody
Summary: Sorrento Therapeutics’ stock has spiked up by 178% since the biotechnology company announced the finding of a COVID-19 antibody on May 15. Sorrento’s stock closed at $2.62 Thursday afternoon and is trading at $7.30, as of the writing. The stock hit $7.62 earlier today at 12:30 pm (EST).
Sorrento Therapeutics’ stock has spiked up by 178% since the biotechnology company announced the finding of a COVID-19 antibody on May 15. Sorrento’s stock closed at $2.62 Thursday afternoon and is trading at $7.30, as of the writing. The stock hit $7.62 earlier today at 12:30 pm (EST).
In the announcement, Sorrento Therapeutics claimed the antibody has demonstrated in preclinical experiments complete inhibition of the SARS-CoV-2 virus infection of healthy cells in four days incubation. The antibody is now being submitted to a peer-reviewed publication.
According to Bitpush Covid-19 Real-time Data, worldwide confirmed cases of COVID-19 has reached 4.5 million. The US ranks top on the list with 1.42 million confirmed cases and 86,386 deaths.
By Yiran Dai
Tags: antibody,COVID-19,Sorrento Therapeutics,Stock
Link: Stock of Sorrento Therapeutics Increased by 178% After the Company Claimed Finding COVID-19 Antibody [Copy]
